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Abstract 
Activation-induced cytidine deaminase (AID) is essential for the generation of antibody 
memory but also targets oncogenes among others. We investigated the transcriptional 
regulation of the Aicda gene, which encodes AID, in the class switch–inducible CH12F3-2 
cells, and found that the Aicda regulation involves derepression by several layers of 
positive regulatory elements in addition to the 5′ promoter region. The 5′ upstream region 
contains functional motifs for the response to signaling by cytokines, CD40-ligand or 
stimuli that activate NF-κB. The first intron contains functional binding elements for the 
ubiquitous silencers c-Myb and E2f and for B cell–specific activator Pax5 and E-box-
binding proteins. The results revealed that the Aicda is regulated by the balance between 
B-cell-specific and stimulation-responsive elements and ubiquitous silencers. 
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Introduction 
Activation-induced cytidine deaminase (AID) is essential for the physiological alterations 
in immunoglobulin genes (Igs) that generate antibody memory, namely, class switch 
recombination (CSR) and somatic hypermutation (SHM)1,2. SHM introduces non-
templated point mutations at a high frequency in the variable (V) regions of antibody 
genes, which, in conjunction with cellular selection mechanisms, give rise to high-affinity 
antibodies. CSR is a region-specific DNA recombination that occurs between two switch 
(S) regions located 5′ to each heavy-chain constant region (CH) gene. This recombination 
juxtaposes a downstream CH gene with the V region gene by excising the intervening CH 
genes. CSR results in immunoglobulin class switching without changing antigen 
specificity3,4.  
AID is responsible for DNA cleavage in both the V and S regions5–8. Since DNA 
cleavage by AID can be deleterious to the genome, its is tightly regulated; virtually no 
expression is observed in non-B cells or even in B cells, unless they have been activated 
by appropriate stimuli, such as lipopolysaccharide (LPS), CD40-ligand (CD40L; 
http://www.signaling-gateway.org/molecule/query?afcsid=A000536), or certain cytokines, 
including interleukin 4 (IL-4; http://www.signaling-
gateway.org/molecule/query?afcsid=A001262), transforming growth factor-β (TGF-β; 
http://www.signaling-gateway.org/molecule/query?afcsid=A002271) and interferon-γ 
(IFN-γ)9,10. Consequently, the transcriptional regulatory system of Aicda should include 
both lineage-specific and stimulus-specific response elements. 
Complicating this picture, AID appears to target not only Ig genes but also the genes 
for several oncogenes that are frequently mutated or translocated to Ig loci in B cell 
malignancies (reviewed in 11). Studies on AID-deficient mice suggest that AID may be 
involved in the pathogenesis of B cell malignancy12–16. Aberrant AID expression in human 
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B cell lymphomas was also speculated to correlate with degree of malignancy11,17. 
Interestingly, infection by certain viruses or bacteria that are potentially tumorigenic can 
induce AID expression in B and non-B cells18–20. Such ectopic expression of AID may 
contribute to tumorigenesis when AID expression persists during chronic infection20–22. In 
support of this idea, systemic overexpression of AID in transgenic animals leads to tumor 
development in various organs22–24.  
Several studies have addressed the mechanism for the transcriptional regulation of 
Aicda. The putative promoter region has been identified immediately upstream of the 
transcription start site (TSS), but this promoter is not lymphocyte-specific25. Two tandem 
E-boxes, recognized by E proteins such as E2A, located in the first intron have been 
proposed to be important for the induction of AID in B cells26. The transcription factor 
Pax5 [http://www.signaling-gateway.org/molecule/query?afcsid=A000403] may play a 
role, in cooperation with E proteins, in the B lineage-specific control of AID expression27. 
However, the location of the functional Pax5 motif is controversial25,27. In addition, the 
functional contributions of proposed putative binding sites for the signal transducer and 
transactivator 6 (STAT6; http://www.signaling-
gateway.org/molecule/query?afcsid=A002236) and nuclear factor kappa B (NF-κB; 
http://www.signaling-gateway.org/molecule/query?afcsid=A001645), located upstream of 
the Aicda promoter, are not yet clear28. Finally, most previous studies were done either in 
cell lines whose AID expression is constitutive, or in primary B cells that had been fully 
stimulated by mitogens. Additional information requires detailed and thorough studies on 
the regulatory elements of Aicda in stable cell lines in which AID expression is inducible. 
In this study, we performed an extensive analysis using luciferase reporter assays to 
determine the functional regulatory elements of the Aicda locus in CH12F3-2 cells. These 
cells carry out CSR with an efficiency as high as 70% upon stimulation with CD40L, IL-4, 
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and/or TGF-β (CIT)29. Because each of these CIT factors is also important for CSR 
stimulation in primary B cells, the control of the induction of AID expression in the 
CH12F3-2 cells is likely to reflect the physiological regulation of Aicda. We identified 
and characterized two clusters of regulatory elements, one about 8 kb upstream of the TSS 
and the other within the first intron. The former contains the major enhancers that respond 
to CIT stimulation, and the latter confers B cell specificity through a combination of B 
cell–specific positive elements and ubiquitous negative regulators. Our results revealed a 
sophisticated regulatory network in which AID expression is controlled by the balance 
among more than a dozen enhancers and silencers. 
 
Results 
Conserved regions in and around the Aicda gene 
      To identify candidates for cis-regulatory elements of the AID gene, we compared the 
mouse and human genomic DNA sequences within 50 kb upstream and downstream of the 
Aicda TSS by using PipMaker and mVISTA pairwise alignments. Consistent with similar 
analyses by others25, we found four relatively well conserved non-coding regions (Fig. 1a 
and Supplementary Fig. 1). Region-1 (–1500 to +101), located immediately upstream of 
the TSS, contains a ubiquitously active promoter25 and the following putative transcription 
factor binding motifs: one for NF-κB, one for STAT6, two for Sp that can bind both Sp1 
and Sp3, and one for HoxC4-Oct (Supplementary Fig. 1b).  
      Region-2 (+121 to +2221), located in the first intron, part of which shows more than 
70% local nucleotide sequence identity between mouse and human. This region contains 
the following binding motifs: two for NF-κB, two for Mzf1, two for Cp-2, three for c-Myb, 
one for Nkx2.5, one for Pax5, two E-boxes, and one E2f-binding site (Supplementary Fig. 
1b). Only the two high-affinity E-box have been well characterized26,27.  
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Region-3 (+16278 to +18378) is located downstream of Aicda at approximately 6 
kb and 25 kb from exon 5 in mouse and human, respectively. This region was reported to 
be required for normal AID expression by BAC (bacterial artificial chromosome) 
transgenic mouse system30. Region-4 (–9224 to –7424), located approximately 8 kb 
upstream of the TSS, has not been studied before, although it contains candidate binding 
motifs for positive regulatory transcription factors, including two for NF-κB, two for 
STAT6, three for enhancer binding protein (C/EBP), and one for Smad3/4 
(Supplementary Fig. 1b).  
 
The Aicda promoter is not CIT-responsive 
To study the cis regulatory elements of Aicda by the luciferase reporter assay, we used 
CH12F3-2 cells, in which AID expression is barely detectable and strongly up-regulated 
by stimulation with CIT, resulting in efficient CSR to IgA9. First, we generated plasmids 
containing serial 5′ deletions of region-1, to examine whether region-1 contributes to AID 
induction by CIT. This region contains several elements that were proposed or 
demonstrated to be involved in Aicda regulation, including an Sp-binding motif25 that was 
originally reported as a putative Pax5 site27, STAT6 and NF-kB sites28, and HoxC4-Oct 
motifs31. We found all the tested constructs showed an approximately 4- to 8-fold increase 
in the luciferase activity, compared with pGL3, the promoter-less luciferase vector. We 
also found weak positive and negative effects in Sp motif and GA-rich sequence of which 
binding factor is unkown, respectively (Fig. 1b). Unexpectedly, however, none of these 
constructs showed any response to the CIT stimulation. The HoxC4-Oct element was 
previously demonstrated to be involved in AID expression using Hoxc4–/– B cells31, but 
this fragment alone did not significantly respond to CIT. The HoxC4-Oct element may be 
involved in the basal expression of AID. 
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Therefore, we extended our analysis to the other conserved regions in order to identify 
CIT-responsive enhancer elements. We also sought stronger B cell–specific enhancer 
elements, because Sp1 and Sp3 are general transcription factors and the activity of the 
HoxC4-Oct motif was minimal, although it is lymphoid specific31,32. Since the 100-bp 
fragment immediately upstream of TSS, containing the Sp and HoxC4-Oct motifs, still 
activated transcription 5-fold, to a level almost equivalent to that induced by the entire 
region-1, we used this fragment as the minimal promoter.  
 
Regulation of the Aicda promoter by regions-2 and -4 
To delineate the role of the conserved regions in the regulation of AID expression, we 
constructed reporter vectors harboring region-1 in combination with regions -2, -3, or -4. 
The addition of region-2 to region-1 decreased the luciferase activity by 50%, and this 
construct did not respond to CIT stimulation (Fig. 1c). On the other hand, a construct 
containing both region-1 and region-4 induced enhanced luciferase activity in response to 
CIT stimulation, and its basal activity was also slightly higher than that of the region-1-
only construct, suggesting that region-4 contains DNA elements responsive to IL-4, TGF-
β and/or CD40L.  
By contrast, the addition of region-3 did not result in any significant change in either 
the basal or CIT-induced AID promoter activity, in contrast to a previous report30 (Fig. 1c). 
Serially deleted region-3 fragments did not show any significant effects on the luciferase 
activity driven by region-1, either (data not shown). Taken together, our data indicate that 
the basal expression of AID in CH12F3-2 is regulated negatively by region-2 and 
positively by region-4 while no enhancer activity was detectable in region-3 by the 
luciferase assay. In addition, region-4 was primarily responsible for the up-regulation of 
the Aicda gene in response to CIT stimulation.  
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Region-2 confers B cell specificity  
To dissect the regulatory elements in region-2, serially deleted region-2 fragments were 
ligated downstream of the luciferase reporter construct driven by the minimal Aicda 
promoter (–101 to +1) (Fig. 2a,b). CIT stimulation did not cause a significant increase in 
the luciferase activity of CH12F3-2 cells expressing any of these constructs, supporting 
the idea that the CIT responsive element is located outside region-2.  
Further study of region-2, to look for B cell–specific regulators, showed that a deletion 
of the 3′ sequence (+1709 to +1783) increased the luciferase activity approximately six 
times over that induced by full-length region-2, suggesting negative regulatory elements in 
the deleted sequence (Fig. 2a, line 4). The further serial deletion of the two E-boxes 
reduced the activity to almost equal that of the minimal promoter (Fig. 2a, lines 5, 6), in 
agreement with a previous report on the enhancer function of these E-boxes26. When the 
Pax5 element was also deleted, the luciferase activity was reduced further (Fig. 2a, line 7).  
To confirm the positive roles of the Pax5 motif and E-boxes, we made constructs with 
only these motifs because the suppressing effect from the adjacent sequences masked their 
activity. The fragment containing only the Pax5 site and the two E-boxes enhanced the 
luciferase activity of the minimal promoter about 3-fold (Fig. 2c, line 4). Mutating any 
one of the three motifs obviously impaired the enhancer activity, indicating that all three 
contributed to the positive regulation of Aicda (Fig. 2c, lines 5-7). Since Pax5 and E 
proteins are well-established B cell–specific co-activators, which actually bind to this 
region in activated B cells26, 27, they could be responsible for the activation of Aicda in B 
cells. In contrast, the NF-κB-3 site (see Fig. 2a for the positions of the numbered motifs) 
did not seem to play a relevant role in either basal or CIT induced- AID expression (Fig. 
2a, line 10 and Fig. 2b, line 4).  
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The negative regulatory region (+1709 to +1789) contains the binding motifs for NF-
κB-4, E2f, Cp2-2, c-Myb-3, and Mzf1-2, but only the E2f-binding site appeared to be 
responsible for the negative regulation by mutagenesis experiments (Fig. 2c, lines 4, 8 and 
9, and Supplementary Fig. 2, lines 8, 9). Deletion of the upstream sequence (+1203 to 
+1530) that contains the Mzf1-1, Cp2-1, c-Myb-1, c-Myb-2, and Nkx2.5 binding motifs 
enhanced the luciferase activity, suggesting the presence of other negative regulatory 
motifs within this region (Fig. 2a, line 9; Fig. 2b, line 7). We excluded the contribution 
from the Mzf1-1 and Cp2-1 motifs by mutagenesis experiments as no significant 
differences were observed relative the intact region (Supplementary Fig. 2, compare lines 
6, 7 with line 5). Although the suppressor activity of a 350-bp CT-rich sequence from 
+874 to +1221 was obvious only in the 5′ deletion construct (Fig. 2a,b), a similar 
sequence has a reported suppressor function in another gene, Cyp1a1, in epidermal 
keratinocytes33. Notably, the activity of the B cell-specific enhancers (the Pax5 site and E-
boxes) was not sufficient to counter the effect of the suppressive elements, including c-
Myb-1, c-Myb-2, Nkx2.5, E2f, and the CT-rich sequence of region-2 (Fig. 1c, Fig. 2a,b). 
 
Suppressor elements in region-2 counteract enhancers 
The interaction between regions-2 and -4 was examined. Region-2 suppressed the 
enhancer activity of region-4 regardless of CIT stimulation (Fig. 2d, line 4). Since region-
4 amplified the luciferase activity strongly, we could confirm suppressor activities 
observed in the deletion experiments. Deletion of the CT-rich sequence together with the 
inactive NF-κB-3 motif led to a slightly higher luciferase activity (Fig. 2d, line 5). 
Additional point mutations in one of the three motifs in this region, namely c-Myb-1, E2f, 
and c-Myb-2 (overlapping the Nkx2.5 site), reduced the suppression activity (Fig. 2d, 
lines 6–8). The combined disruption of all these motifs along with the CT-rich region 
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almost completely abolished the suppressor activity of region-2 (Fig. 2d, line 9). Although 
the involvement of Nkx2.5 cannot be formally excluded, the knockdown experiment with 
siRNA oligonucleotides for c-Myb but not for Nkx2.5 increased the luciferase activities 
(Supplementary Figs. 3,4). Taken together, these results indicate that the binding motifs 
in region-2 for c-Myb and E2f, and the CT-rich sequence, function independently as 
suppressor elements to counteract the positive elements in region-2 and region-4.  
 
Elements responsible for CIT stimulation in region-4 
IL-4, TGF-β and CD40L induce AID expression independently and additively in 
CH12F3-2 cells9. To confirm that region-4 contains independent response elements for 
IL4, TGF-β or CD40L, each stimulation was separately examined. IL-4, TGF-β, and 
CD40L individually up-regulated the luciferase activity of the construct carrying region-4 
(Fig. 3a). Combining the three stimuli resulted in the highest activity, and the increment 
appeared to be additive. 
To identify the functional elements in region-4, a series of deletion constructs was 
generated (Fig. 3b,c). The inductive response to CIT stimulation greatly decreased by the 
deletions of the DNA region containing STAT6-1 (see Fig. 3b line 5), STAT6-2 (Fig. 3c, 
line 4), NF-kB-2 (Fig. 3b, line 6), Smad3/4 (Fig. 3c, line 6), C/EBP-1 (Fig. 3b, line 7), 
and C/EBP-2 (Fig. 3c, line 7). Among these elements, NF-kB-2 and two tandem C/EBP 
motifs seem to have strong contribution to the basal activity as well. In contrast, the 
deletions of the DNA region containing NF-kB-1 (Fig. 3b, line 4) and C/EBP-3 (Fig. 3c, 
line 5) elements had no effect on the luciferase activity. 
The mutagenesis experiments confirmed the involvement of the region-4 elements. 
Mutations of either or both of the STAT6-binding sequences strongly reduced the 
luciferase activity induced by IL-4 alone as well as by CIT, indicating that both sites are 
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response elements for the IL-4 signal (Fig. 4a, lines 4–7). STAT6 knockdown almost 
completely blocked the luciferase induction by IL-4 stimulation (Fig. 4b and 
Supplementary Fig. 5). We conclude that the IL-4 signal activates the Aicda promoter 
through the STAT6-1 and –2 binding sites on region-4.  
Destruction of the NF-κB-2 motif severely impaired the response to both CD40L alone 
and to CIT (Fig. 4c, line 4), and the NF-κB-specific inhibitor, sulfasalazine, almost 
completely suppressed the luciferase induction by CD40L through region-4 (Fig. 4d and 
Supplementary Fig. 6). The inactivation of NF-κB also reduced the basal activity.  
When the Smad3/4 site was mutated, the TGF-β response and the basal activity were 
clearly suppressed (Fig. 4e, line 4). Furthermore, in agreement with the deletion 
experiment results, the two C/EBP binding sites were required for the response to both 
TGF-β alone and to CIT (Fig. 4f, lines 4, 5). Thus, the pair of C/EBP sites was required 
for the region-4 response to all three CIT components: IL-4, CD40L and TGF-β. However, 
the C/EBP sites alone did not respond to CIT stimulation (Fig. 4g), indicating that the pair 
of C/EBP sites is required but not sufficient.  
Finally, we examined whether the CIT response was dependent on the B cell–specific 
enhancers (Pax5-binding site and E-boxes) of region-2 when the repressor elements co-
exist. Deletion of Pax5-binding site and E-boxes from the reporter construct containing 
regions-2 and -4 still showed clear induction by CIT although the luciferase activity was 
reduced to about 35% (Fig. 5a, lines 4, 5). These results indicate that the B cell–specific 
enhancers are not absolutely essential for the CIT response through region-4, at least in 
our luciferase system.  
The same constructs used above were tested in two non-B cells, 2B4.11 T cells and 
NIH3T3 fibroblastic cells. The basal luciferase activity in CH12F3-2 cells by the region-4 
reporter alone was approximately twice that observed in the non-B cells, indicating that 
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CH12F3-2 cells express more intrinsic factors for AID expression than non-B cells (Fig. 
5b, line 3). Addition of region-2 repressed the basal activity not only in the B cells but also 
in the other lineage of cells, indicating that the region-2 silencers are active in non-B as 
well as B cells (Fig. 5b, line 4). Importantly, the deletion of the Pax5-binding site and E-
boxes reduced the luciferase activity only in B cells (Fig. 5b, lines 5).  
 
Involvement of candidate transcription factors 
To examine in vivo binding of the transcription factors to the candidate regulatory 
elements, we performed chromatin immunoprecipitation (ChIP) assay of region-2 or -4 
(Fig. 6a). Twelve-hour cultivation with CIT significantly induced the specific binding of 
transcription factors, NF-κB, C/EBPβ, STAT6 and Smad4 to region-4 in CH12F3-2 cells 
(Fig. 6b). We tried c-Myb and some of E2f proteins (E2f-1, -4 and -5) without success 
partly because of the absence of high-quality antibodies (data not shown). C/EBPβ and 
STAT6 also bound to region-4 in spleen B cells activated by LPS and IL-4 (Fig. 6c). 
Binding of Pax5 and E-proteins to region-2 was already demonstrated26,27.  
To confirm involvement of these transcription factors in Acida regulation, we examined 
their expression profile in stimulated spleen B cells (Fig. 7). mRNAs of STAT6, NF-kB, 
Smads, C/EBPs, Pax5, E2a, cMyb, E2f-2 and -4 were rapidly induced by stimuli of LPS, 
IL-4 and TGF-β,  declined by 12 h, and maintained thereafter. Expression of E2f-7 and -8, 
which can repress by binding to the E2f motif34, increased 20 h after stimulation in parallel 
with AID expression. We also compared the expression of these factors in naïve and 
germinal center (GC) B cells. Most of the activators were already well-expressed in naïve 
cells, suggesting the activation of their function by the protein modification after 
stimulation (Supplementary Fig. 7). Expression of repressive E2fs, namely E2f-5, -7 and 
-8, and cMyb were increased in GC B cells. Since the suppressive elements were 
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functional in CIT stimulated CH12F3-2 cells, the increased expression of candidate 
repressor proteins (E2f and c-Myb) in activated B cells may be a feedback response to 
avoid the over-expression of AID (Supplementary Fig. 8).  
 
Discussion 
In the present study, we identified three functionally important regions in the 10-kb region 
upstream of the Aicda gene and within it. Region-1 serves as the basic promoter, and 
contains positive elements, Sp-binding sites, and a HoxC4-Oct motif, and a weak negative 
element, the GA-rich sequences. Region-2, located in the first intron of Aicda, also 
contains both positive (Pax5-binding site and E-boxes) and negative (c-Myb- and E2f-
binding sites) elements. On balance, region-2 functions as a negative regulator when 
combined with region-1. Here we showed that the Pax5-binding site and E-boxes in 
region-2, contribute to the restriction of AID expression to the B cell lineage. Region-4 
contains the functional binding sites for NF-κB, STAT6, and Smad3/4, which are, 
respectively, response elements for CD40L, IL-4 and TGF-β. A tandem pair of C/EBP 
binding sites is required for each of these elements to respond to CIT stimulation. A 
similar requirement for a tandem pair of C/EBP elements has been reported for the gene 
encoding the common β-chain of the IL-3, IL-5, and GM-CSF receptors35.   
         Because AID promotes genome-wide damage and leads tumorigenesis, the promoter 
activity should be finely regulated. In fact, AID expression virtually restricted to activated 
B cells. How could such a restricted expression be achieved by the elements we found in 
this study? Perhaps, the key is the negative elements in region-2. These counteract against 
positive signals mediated from cytokine- or Toll-like-receptors (TLR) which are widely 
expressed. They also work against B cell-specific enhancers, of which binding proteins are 
functional even in non-activated B cells, thereby would confer the active transcription 
  14 
only in activated B cells.  
         C-Myb often functions as a transcription activator, but it also represses many 
genes, including Cd4, Nras, c-erbB-2 (refs. 36-38). Interestingly the repressive c-Myb-
binding site of the Cd4, whose expression is tightly regulated during T cell development, 
is also located in the first intron38. Some E2f proteins such as E2f-4, E2f-5, E2f-6 can 
reversibly repress a promoter in conjunction with other co-repressors39. The E2f protein 
can also induce stable repression by recruiting the polycomb complex40. Such a 
mechanism might be involved in the complete silencing of Aicda in non-lymphoid cells. 
Interestingly, we found increase of E2f-7 and -8 in in vitro activated and GC B-cell. E2f-7 
and -8 counteract activating E2fs 34. Given activating E2fs were also up-regulated in GC 
cells, they might bind to region-2 in certain condition, and E2f-7 and -8 would counteract 
against them. We could not detect any enhancer activity to the E2f site in region-2, but it 
could be due to the expression pattern of E2fs in CH12F3-2 which is repressor type 
dominant (not shown). It still remains unsolved which E2f proteins are actually 
responsible to the repressive function in region-2.  
We found discrepancies between our results and previous studies on AID regulation. An 
active Pax5 binding site in region-1 was proposed, but later another group concluded the 
site is in fact an Sp-binding site25,27. Our mutagenesis experiments strongly indicated the 
Pax5 involvement, but the responsive site is the one in region-2. Another discrepancy was 
our inability to detect enhancer activity in region-3, which was reported to be required for 
AID expression in the BAC transgenic mouse30. Region-3 might contain a positive 
regulator which works only in the chromatin context.  
Our study suggests that the region-4 is essential for the AID response in B cells to the 
environmental stimulation delivered by T cells, dendritic cells, and other cytokine-
producing cells. Immature B cells were reported to express low amounts of AID by 
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signaling through TLR41,42. Furthermore it was shown that even gastric epithelial cells or 
hepatocytes can express AID upon infection20,21. The mechanism for this AID induction is 
not clear from our studies in B lineage cells. The NF-κB site in region-4 could be involved 
in the AID-induction signal via TLR or other pathways in response to bacterial or viral 
infection43. Negative regulators binding to the elements in region-2 should counteract NF-
κB under normal conditions, to suppress the Aicda gene and retain genomic stability. We 
were unable to identify a candidate response element for IFN-γ (STAT1-binding site). 
Since IFN-γ can activate the NF-κB pathway44, and also because STAT1 can form a 
heterodimer with other STAT proteins including STAT6 (ref. 45), the Aicda regulation by 
IFN-γ would not need an obvious STAT1-binding motif. We could not test this hypothesis 
because CH12F3-2 cells do not respond to IFN-γ. We were unable to test the effect of B 
cell receptor signaling in CH12F3-2 cells because it affects CSR only marginally (data not 
shown). 
Our current assay system has obvious limitations for recapitulating the complete 
repression of Aicda by silencers. The luciferase assay depends on transient transfection 
with high dose of plasmid DNA whose regulation might be different from that of the 
endogenous Aicda gene. However, ChIP analyses and expression profiles of candidate 
transcription factors in CH12F3-2 and spleen B cells are in general agreement with the 
conclusion derived from the luciferase assay. The next step to confirm our findings will be 
in vivo mutagenesis using either gene targeting or BAC transgenic strategies.  
In summary, our findings emphasize that two separate regions, region-2 and region-4, 
carry out physiologically distinct regulatory functions in Aicda expression in which 
derepression from the effects of silencers by B lineage–specific and stimulation-
responsive enhancers is critical. The evolution of such a sophisticated regulatory system 
for the Aicda locus seems reasonable, even necessary, since its product is essential to 
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antibody memory but has the potential to induce genomic instability. 
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Figure legends: 
Figure 1. The general characterization of regions-1 ~ -4 by luciferase reporter 
plasmids. (a) A diagram of mouse Aicda locus. The positions of region-1 to -4 relative to 
five exons are indicated. (b) Luciferase constructs with full-length or deletion mutants of 
region-1, which carries the Aicda promoter, were analyzed. The structure of each construct 
is shown schematically. The plasmids were introduced into CH12F3-2 cells and cultured 
with or without CIT stimulation for 24 h. The positions of the candidate regulatory 
elements are indicated by the specific symbols at the top of the diagram. Open and filled 
bars indicate cultures with and without CIT stimulation, respectively. (c) Effects of 
regions-2, -3, and -4 on the Aicda promoter in region-1 were analyzed. Each region was 
ligated to the luciferase coding sequence as shown. Luciferase activities of each construct 
with or without CIT stimulation are shown as the ratio relative to non-stimulated pGL3 
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(top of each panel). Luc, luciferase coding sequence; R1, region-1; R2, region-2; R3, 
region-3, and R4, region-4. Data are representative of three independent experiment (mean 
+/– s.d.). 
 
Figure 2. Region-2 contains both enhancer and suppressor elements. Firefly-luciferase 
reporter plasmids for region-2 were made in conjunction with the minimal Aicda promoter 
(-101 ~ -1; black bar). Full-length and region-2 fragments with serial deletions from either 
the 5′-end (a) or 3′-end (b) were used. Numbers on the diagram give positions relative to 
the TSS. Candidate elements are indicated at the top of panel a. Note that the c-Myb-2 site 
includes Nkx2.5, but is illustrated as two symbols that contact each other. Binding motifs 
that appear in more than one place are distinguished by a number after the motif name. (c) 
Constructs carrying the Pax5 motif and E boxes of region-2 were made as shown. (d) The 
luciferase construct with full-length region-4 and -2, designated as pR4-R2paidLuc, and 
its derivative plasmids with the deletions and mutations shown in the diagram, were 
generated and analyzed. The luciferase activities of each construct with or without CIT 
stimulation are shown as the ratio relative to non-stimulated pGL3 (top of each panel). 
Filled and open bars indicate activities with and without CIT stimulation, respectively. 
Elements destroyed by mutagenesis are indicated by arrows. Data are representative of 
three independent experiment (mean +/– s.d.). 
 
Figure 3. Analysis of CIT-responsive elements in region-4. (a) CH12F3-2 cells were 
transfected with a luciferase construct containing the minimal Aicda promoter and region-
4, pR4paidLuc, to analyze the response to IL-4 (line 4), TGF-β (line 5), and CD40L (line 
6). Candidate response elements in region-4 are indicated by specific symbols on the 
diagram with their names indicated above. The stimuli used for each experiment are 
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indicated at the left of each construct. Luciferase activities of each construct with or 
without CIT stimulation are shown as the ratio relative to the non-stimulated pGL3 (top). 
The enhancer activity was identified by a making serial deletions of region-4 from the 5′-
end (c) and the 3′-end (c) as indicated. Filled and open bars indicate with and without CIT 
stimulation, respectively. Data are representative of three independent experiment (mean 
+/– s.d.). 
 
Figure 4. Elements in region-4 that are responsive to the CIT stimulation.  
Transfected CH12F3-2 cells were cultured for 24 h with no stimulation, IL-4, CD40L, 
TGF-β, or CIT as indicated in each panel. (a) Mutations or deletions were introduced to 
STAT6 elements on the pR4paidLuc plasmid as illustrated by arrows or the deletion of 
symbols, respectively. (b) CH12F3-2 cells were transfected with pR4paidLuc constructs 
and three kinds of RNAi oligonucleotide (#1-#3) for STAT6 (Supplementary Table 1), 
as well as with the control low GC oligonucleotide. (c) Mutation of the NF-kB-2 element 
in region-4 in pR4paidLuc reduced the luciferase activity in response to CD40L and CIT. 
(d) An NF-κB specific inhibitor, sulfasalazine, inhibited the enhancer activity of region-4 
in pR4paidLuc in response to CD40L and CIT (e) Mutations of the Smad3/4 element 
reduced the luciferase activity of pR4paidLuc in response to TGF-β and CIT. (f) 
Luciferase assay showing the requirement for C/EBPs for the TGF-β response of 
pR4paidLuc and its derivative plasmids that have deletions or mutations as indicated in 
the diagram. (g) Modified pR4paidLuc plasmids with deleted C/EBP motifs or only the 
two C/EBP motifs of region-4 were constructed and analyzed. Data are representative of 
three independent experiment (mean +/– s.d.). 
 
Figure 5. Roles of Pax5 and E proteins in non-B cells. Deletion of binding sites for 
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Pax5 and E proteins in region-4 of the pR4-R2paidLuc plasmid were generated as shown. 
(a) Pax5 and E protein contribute to the induction of AID expression in B cells. CH12F3-2 
cells were transiently transfected with reporter constructs and cultured for 24 h with (filled 
bars) or without (open bars) CIT stimulation. Luciferase activities of each construct with 
or without CIT stimulation are shown as the ratio relative to non-stimulated pGL3 (top). 
(b) The reporter plasmids were introduced by transient transfection into CH12F3-2, 
2B4.11 (T cell line), and NIH 3T3 (fibroblast cell line) cells and cultured for 24 h without 
stimulation. Luciferase activities of each construct in each cell line are shown as the ratio 
relative to that in CH12F3-2 cells transfected with pGL3 (top). Data are representative of 
three independent experiment (mean +/– s.d.). 
 
Figure 6. In vivo binding of the transcription factors examined by ChIP assay. (a) The 
diagram shows the positions detected by real-time PCR. (b) CH12F3-2 cells cultured with 
or without CIT for 12 h were fixed for indicated time periods, and used for ChIP with 
antibodies against transcription factors shown in each panel. Difference between values 
from CIT stimulated (filled) and non-stimulated (open) samples was evaluated by one tail 
paired t-test. Data are representative of three (Stat6 and Smad4), five (p65), or six(C/EBPβ 
and control IgG) independent experiment (mean + s.d.). (c) Spleen B cells isolated from 
wild-type mice were cultured with LPS and IL-4 for 3 days and analyzed by ChIP. 
Difference between each region and silent gene, Icos, was analyzed. Data are 
representative of three independent experiment (mean + s.d.). *, P < 0.05; **, P < 0.01. 
Actual P values are also shown.  
 
Figure 7. Expression time-course of candidate transcription factors for Aicda 
regulatory regions.  Purified spleen B cells from 3 mice were pooled and stimulated with 
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indicated stimulants. Cells were harvested at indicated time points after the stimulation 
and mRNA expression of indicated proteins were measured by RT-qPCR. Signals were 
mormalized by GAPDH signals. Data representative of two independent experiments. a.u., 




Cells, reagents and mice 
CH12F3-2 cells, a subline of CH12F3 cells, were cultured and stimulated by a 
combination of 2.5 μg/ml IL-4, 1 μg/ml TGF-β, and CD40L as described29. Culture 
supernatant from J558 cells transfected with pHβApr-1neomCD40L-mCD8α plasmid was 
used as the source of CD40L at 40% volume of culture medium29. The NF-κB-specific 
inhibitor, sulfasalazine, was purchased from Sigma-Aldrich. The sequences of the siRNA 
oligonucleotides for Stat6, Myb, and Nkx2-5 knockdown (Invitrogen) are indicated in 
Supplementary Table 1. Animal studies were approved by Animal Research Committee 
of Graduate School of Medicine, Kyoto University. Mice were kept in specific pathogen 
free condition. Spleen B cells were purified by magnetic sorting with CD43 beads 
(Miltenyi Biotec). B cells were cultured with combination of IL-4 (10 ng/ml), LPS (20 
µg/ml) and TGF-β (10 ng/ml).  
 
Sequence alignment and identification of regulatory elements 
The DNA sequence alignment and dotplot matrix sequence comparisons were performed 
using PipMaker46 and the BLAST2 algorithms47. Identification of regulatory elements in 
the conserved region of the AID gene was conducted with the programs MOTIF search 
(http://motif.genome.jp/) and rVISTA48. 
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Construction of plasmids and PCR-mediated mutagenesis 
Region-1 to region-4, which contained putative Aicda regulatory elements, were amplified 
from genomic clones containing Aicda by PCR. The amplified region-1 fragment was 
digested with Nco I and Xho I and cloned into the pGL3-basic vector (Promega) upstream 
of the firefly luciferase coding region. The region-4 DNA was digested with Xho I and 
Kpn I and ligated upstream of region-1. Regions-2 and -3 were digested by Bam HI and 
Sal I and cloned downstream of the luciferase sequence. The relative positions and 
orientations of the regions were chosen according to their arrangement in the Aicda locus. 
Serial deletion mutants were generated by PCR with primers corresponding to each 
deletion site (Supplementary Table 2). Mutations at the putative binding sites of 
regulatory elements were generated by the QuickChange Site-Directed Mutagenesis kit 
(Stratagene). Point mutations introduced into each element are shown in Supplementary 
Table 3. All constructs were verified by DNA sequencing and restriction enzyme mapping. 
 
Transient reporter assay 
CH12F3-2 cells were transiently transfected with equimolar amounts of reporter plasmids, 
using the Amaxa nucleofection technology™ (Amaxa), according to the manufacturer’s 
instructions. The general transfection efficiency of this procedure was more than 75%, as 
monitored by a GFP reporter plasmid. All transfections included 50 ng of phRL Renilla 
luciferase expression construct (Promega), driven by the CMV immediate early promoter, 
as an internal control. The cells were cultured for 24 h with or without stimulation before 
being harvested. Luciferase activity was measured using the Dual Luciferase Assay kit 
(Promega) by EnVision 2103 Multilabel Reader (PerkinElmer). The Firefly luciferase 
activities were normalized to the Renilla luciferase activity, and calculated as the fold 
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change from pGL3-basic (promoter-less control plasmid; Promega), without CIT 
stimulation. 
 
RNA extraction, semiquantitative RT-PCR. 
Total RNA was extracted by using TRIzol (Invitrogen) or RNeasy mini-kit (QIAGEN), 
according to the manufacturer’s instructions. Complementary DNA was synthesized with 
the TaqMan RT-PCR kit (Applied Biosystems) and analyzed by ABI 7900HT real-time 
PCR machine (Applied Biosystems). In time course experiment, qPCR was done with 
LightCycler 480 thermal cycler using SYBER Green Supermix (Roche). The primers used 
are indicated in Supplementary Table 4 and 5. 
 
Chromatine immunoprecipitation assay and statistical analysis. 
Cells were fixed by 1% formaldehyde for 2 or 30 min at 22-26 º C . The cross-linking was 
terminated by 150 mM of glycine. After washing by ice cold PBS twice, cells were lysed 
by sonication in the SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris, pH8.0). 
Debris were removed by centrifugation and cleared lysate was used for immuno-
precipitation. Rabbit polyclonal antibodies for Stat6 (sc-981), NF-kB p65 (sc-109), Smad4 
(sc-7145), and C/EBPβ (sc-150) were purchased from Santa Cruz biotechnology. DNA 
was purified from the precipitates and contents of each specific DNA locus were measured 
by real-time PCR (iQ sybr green supermix, Bio-Rad). Multiple results were evaluated by 
paired one-tail t-test. Primers used were: region-2a (R2a), 5′-
CCACTTAATTACATCCTGAGCCC-3′ & 5′- CTATAAACCCAGAAGCAGCTCA-3′; 
region-2b (R2b), 5′- AGGGACATCCCGAGGAGAG-3′ & 5′- 
GAGCTGCACAGTCCTGACCT-3′; region-4#a (R4a), 5′-
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AAATCGGGGAATGCAGAAGT-3′ & 5′-TCCTCGGGTCACTATTTTTGG-3’; region-4b 
(R4b), 5′-GGGACTGGAAAATGGTTTTTG-3′ & 5′-GATGCCGTACACATGCCATA-3′. 
 
Gene array analysis 
Naïve and GC B cells were sorted from B57BL/6 mice immunized with keyhole limpet 
hemocyanin by FACSAria (Becton Dickinson) according to the staining with B220, PNA 
and Fas. Total RNA was purified by Trizol (Invitrogen) and used for gene chip analysis 
(mouse genome 430 2.0 array; Affymetrix). Signals were normalized by Genespring GX 
7.3 software with GC-RMA method and selected transcription factors were plotted. 
 
Accession number of gene array data. 
The micro-array data in this publication have been deposited in NCBI database with the 
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Supplementary Figure 1. Conserved regions in the Aicda locus. (a) Highly conserved regions between 
human (vertical) and mouse (horizontal) are designated as regions-1 to –4, as shown by dot-matrix plots in 
which the numbers indicate base positions relative to the mouse TSS: Region-1 (-1500 ~ +101), region-2 
(+121 ~ +2221), region-3 (+16278 ~ +18378), and region-4 (-9224 ~ -7424). A schematic diagram of mouse 
Aicda is shown below. Boxes and an arrow indicate the exons and TSS, respectively. (b) DNA sequence 
alignment of transcription regulatory elements conserved between mouse (upper) and human (lower). 
Vertical lines indicate conserved nucleotides in the two species. Candidate elements are indicated by italic 
letters with the consensus binding motifs below. Mutations generated for the functional assays are shown 
below the consensus sequences. The numbers above the alignments indicate the nucleotide positions relative 
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Supplementary Figure 2. Mutagenesis of Mzf1, Cp-2 and c-Myb elements in region-2. The
luciferase construct with full length of region-4 and -2 (pR4-R2paidLuc) and its derivative
plasmids with deletion and mutations as illustrated in the diagram were generated and analyzed.
Mutated elements are indicated by arrows. Constructs were transiently transfected into CH12F3-2
cells and cultured for 24 h with no stimulant (open bars) or with CIT (filled bars). Data are
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Supplementary Figure 3. Minor role of Nkx2.5 in Aicda repression.  (a) RNAi
oligonucleotides for Nkx2.5 (#1-#3) and the control med GC oligo were co-transfected into
CH12F3-2 cells with the plasmid carrying region-4 and repressor sequence of region-2 as
indicated. The activity was analyzed after 24 h culturing with no stimulant (open bars) or
CIT (filled bars). Data are representative of three independent experiments (mean +/– s.d.).
RNA oligonucleotide sequences are shown in Supplementary Table 3. (b) RT-PCR with
Nkx2.5 specific primers indicated the suppression by RNAi oligos. Data are representative
of two independent experiments.
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Supplementary Figure 4. Knockdown of c-Myb reveals its suppressive function. (a) A plasmid
carrying region-4 and region-2 repressive elements was transfected into CH12F3-2 cells with three
kinds of c-Myb RNAi oligonucleotide (#1-#3) as well as with the control med GC oligonucleotide
as indicated. Transfected cells were cultured for 24 h with no stimulant (open bars) or CIT (filled
bars). Data are representative of three independent experiment (mean +/– s.d.). RNA
oligonucleotide sequences are shown in Supplementary Table 3. (b) c-Myb expression were












































































Supplementary Figure 5. STAT6 RNAi suppressed endogenous AID expression and IgA
class switching in CH12F3-2 cells. CH12F3-2 cells were transfected with STAT6 RNAi
oligonucleotide (#1) or low GC oligonucleotide control and cultured for 24 h with or without
CIT stimulation. (a)  Total RNA was extracted and semi-quantitative RT-PCR was performed to
evaluate endogenous AID and STAT6 expression. (b) CSR activity was assessed by percentage
of IgA surface expression in STAT6 RNAi and low GC control transfected cells. The result
shown in this figure is oligo #1; the other oligonucleotides (STAT6 #2 and #3) gave essentially
the same result. The data representative of two independent experiments.
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Supplementary figure 6. Effect of sulfasalazine to endogenous AID expression and IgA
class switching in CH12F3-2 cells. CH12F3-2 cells were cultured with NF-κB specific
inhibitor, sulfasalazine, at 5 µM for 24 h with or without CIT stimulation. (a)  Total RNA
was extracted and the expression of AID was evaluated by semi-quantitative RT-PCR. (b)
FACS profile shows the CSR activity by percentage of IgA surface expression. Data are
representative for two independent experiments.





















Supplementary Figure 7. The mRNA expression of transcription factors in naive and
GC B cells. Expression of transcription factors in naive and GC B cells were analyzed by
Affymetrix mouse genome 430 2.0 gene chip array. Data from two independent gene chip
hybridization results for each condition were compiled. Two dimensional plot of
normalized signal from each probe spot were shown. For the summary table, the expression
pattern of the candidate factors were categorized. A plot within two diagonal lines of
double-fold to both direction was judged as No change. Because generally more than one
values were obtained to each genes from multi-probes, genes that showed the shift in more
than half of plots were judged as Up or Down.
Summary of the differential expression plot:
expression in GC cells relative to naïve cells.
Smad3, C/EBPζDown






































Supplementary Figure 8. Proposed model for the transcriptional regulation of
Aicda expression in B cells. The cytokine-responsive and differentiation-dependent
regions in the Aicda locus are illustrated. Hatched boxes indicate Aicda exons.
Functional elements in each region are indicated with symbols. Binding of c-Myb
and E2f independently repress AID expression. When B cells are activated by
appropriate stimuli for inducing the binding of STAT6, Smad3/4, C/EBP, or NF-κB,
AID expression is derepressed. B cell–specific factors, namely Pax5 and E protein,
contribute to restricting the induction of AID to B lineage cells.
Supplementary Table 1. RNAi oligos used in the knockdown assay. 

























































Supplementary Table 2. Primers used for generating deletions in conserved 
regions. Serial deletions in the conserved regions were generated both from 3’- and 
5’-end. A restriction endonuclease site was inserted to each terminus of primer for 







































































Supplementary Table 3. Primers used to introduce point mutations in the putative binding site of regulatory elements. Mutation was 
























































































Supplementary Table 5. Primers used for RT-qPCR 
AID Sense   CGTGGTGAAGAGGAGAGATAGTG 
  Anti-sense   CAGTCTGAGATGTAGCGTAGGAA 
 STAT6 Sense   TGGCTGACTGGCTGGAGAG 
  Anti-sense   CTGAAGACGCTGGACTGTGG 
NF-Kb1 Sense   GCAACAGATGGGCTACACAGAGG 
  Anti-sense   AGGAAGACGAGAGAGGCAGACAG 
 Smad3 Sense   CGAGAAGGCGGTCAAGAG 
  Anti-sense   CAGGCGGCAGTAGATAACG 
 Smad4 Sense   GTCTGTCTGCTGCTGCTG 
  Anti-sense   GCTCGGTGAAGGTGAATCTC 
 Pax5 Sense   AGTCTCCAGTGCCGAATG 
  Anti-sense   TCCGTGGTGGTGAAGATG 
 c-Myb Sense   CGGACGGACTGATAATGC 
  Anti-sense   GCTGAGATGGAGGTGAGG 
 CEBPb Sense   CGACGAGTACAAGATGCG 
  Anti-sense   TGCTCCACCTTCTTCTGC 
 CEBPg Sense   TTACAGCAGGTTCCTCAGC 
  Anti-sense   GCGGTATTCGTCACTATTCC 
 CEBPz Sense   ACCTGTGGCGTTCCTTGC 
  Anti-sense   TCCTCCTCGTCTTCCTCATCC 
 E2f1 Sense   GGAAAGGGAGAGGGAGAC 
  Anti-sense   CATAGGAAGGACGCATACC 
 E2f2 Sense   GGCAACTTCAAGGAGCAGAC 
  Anti-sense   GGCACAGGTAGACTTCAATGG 
 E2f4 Sense   TTCTACACCTCCACCTCTG 
  Anti-sense   CACCACTGTCCTTGTTCTC 
 E2f7 Sense   CCTCAAGTTCCACAGACC 
  Anti-sense   CACTCAGAAGCAACATAGC 
 E2f8 Sense   GAGTCGGAAGGAGAAGAGC 
  Anti-sense   CCAGGCAGATGTCGTTATTC 
 Tcfe2a Sense   TTCCCTCCCTGACCTCTC 
  Anti-sense   GGCTACTGATGCGATTTCC 
GAPDH Sense   TGTGTCCGTCGTGGATCTGA 
  Anti-sense   CCTGCTTCACCACCTTCTTGAT 
 
